前往化源商城

Assay and Drug Development Technologies 2015-11-01

High-Content Assay Multiplexing for Toxicity Screening in Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Hepatocytes.

Fabian Alexander Grimm, Yasuhiro Iwata, Oksana Sirenko, Michael Bittner, Ivan Rusyn

文献索引:Assay Drug Dev. Technol. 13 , 529-46, (2015)

全文:HTML全文

摘要

Cell-based high-content screening (HCS) assays have become an increasingly attractive alternative to traditional in vitro and in vivo testing in pharmaceutical drug development and toxicological safety assessment. The time- and cost-effectiveness of HCS assays, combined with the organotypic nature of human induced pluripotent stem cell (iPSC)-derived cells, open new opportunities to employ physiologically relevant in vitro model systems to improve screening for potential chemical hazards. In this study, we used two human iPSC types, cardiomyocytes and hepatocytes, to test various high-content and molecular assay combinations for their applicability in a multiparametric screening format. Effects on cardiomyocyte beat frequency were characterized by calcium flux measurements for up to 90 min. Subsequent correlation with intracellular cAMP levels was used to determine if the effects on cardiac physiology were G-protein-coupled receptor dependent. In addition, we utilized high-content cell imaging to simultaneously determine cell viability, mitochondrial integrity, and reactive oxygen species (ROS) formation in both cell types. Kinetic analysis indicated that ROS formation is best detectable 30 min following initial treatment, whereas cytotoxic effects were most stable after 24 h. For hepatocytes, high-content imaging was also used to evaluate cytotoxicity and cytoskeletal integrity, as well as mitochondrial integrity and the potential for lipid accumulation. Lipid accumulation, a marker for hepatic steatosis, was most reliably detected 48 h following treatment with test compounds. Overall, our results demonstrate how a compendium of assays can be utilized for quantitative screening of chemical effects in iPSC cardiomyocytes and hepatocytes and enable rapid and cost-efficient multidimensional biological profiling of toxicity.

相关化合物

结构式 名称/CAS号 全部文献
过氧化氢 结构式 过氧化氢
CAS:7722-84-1
甲醛 结构式 甲醛
CAS:50-00-0
佛司可林 结构式 佛司可林
CAS:66575-29-9
二甲基亚砜 结构式 二甲基亚砜
CAS:67-68-5
抑癌蛋白M 结构式 抑癌蛋白M
CAS:106956-32-5
盐酸阿霉素 结构式 盐酸阿霉素
CAS:25316-40-9
维生素K3 结构式 维生素K3
CAS:58-27-5
碳酸氢钠 结构式 碳酸氢钠
CAS:144-55-8
硫酸链霉素 结构式 硫酸链霉素
CAS:3810-74-0
一水西沙必利 结构式 一水西沙必利
CAS:260779-88-2